Sanders et al. demonstrated that tau, the signature protein of tauopathies, forms biochemically and morphologically distinct oligomers accounting for different disease phenotypes, with AD inclusions showing the most homogenous composition (Sanders et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.